A 2013 meta-analysis of 17 randomized, placebo-controlled studies in a total of 1,625 participants with heart failure found that oral L-carnitine (1.5-6 g/day for seven days to three years) significantly improved several measures of cardiac functional capacity (including exercise tolerance and markers of the left ventricle function), yet had no impact on all-cause mortality (56)
FDA approval dates to 1959, making it one of the longest-studied weight-loss agents, though data on long-term safety beyond 12 weeks remains limited
Giralt, M., Lafuente, A., Pujol, F
Nausea affects 15-44% of patients, particularly during initial treatment or dose increases
GLP-1 therapies have been established using two main approaches: DPP4-resistant GLP-1 agonists/GLP-1RA and DPP-4 inhibitors, both of which aim to prolong the life-time of circulating GLP-1(736) amide
Increased rate of gluconeogenesis in type II diabetes mellitus